Abstract
Varicose veins have been recognised since the time of the Papyrus of Ebers (c. 3500 BC) and venous ulceration from the works of Hippocrates, and yet the pathogenesis of these conditions is incompletely understood. Many factors are involved in the development of venous ulceration. These probably include those which also cause varicose veins and involve both inherited and environmental components. Inherited factors have been shown to be important in the pathogenesis of varicose veins [1], but a detailed analysis of genetic factors in patients with leg ulcers has not been published. Recently an association has been shown between factor V Leiden gene defect and venous ulceration [2]. This may simply reflect the increased likelihood of deep vein thrombosis (DVT) in patients with this gene defect, or may be related in a more complex way to the development of venous ulceration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cornu-Thenard C, Boivin P, Baud J-M, de Vincenzi I, Carpentier PH. Importance of the familial factor in varicose disease. J Dermatol Surg Oncol 1994;20:313–326.
Grossman D, Heald DW, Wang C, Rinder HM. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers. J Am Acad Dermatol 1997;37:409–413.
Wille-Jorgensen P, Jorgensen T, Andersen M, Kirchhoff M. Postphlebitic syndrome and general surgery: an epidemiologic investigation. Angiology 1991;May:397–403.
Mudge M, Leinster SJ, Hughes LE. A prospective 10-year study of the post-thrombotic syndrome in a surgical population. Ann R Coll Surg Engl 1988;70:249–252.
Baker SR, Stacey MC, Jopp-McKay AG, Hoskin SE, Thompson PJ. Epidemiology of chronic venous ulcers. Br J Surg 1991;78:864–867.
Strandness DE, Langlois Y, Cramer M, Randlett A, Thiele BL. Long-term sequelae of acute venous thrombosis. JAMA 1983;250:1289–1292.
Franzeck UK, Schalch I, Jager KA, Schneider E, Grimm J, Bollinger A. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zurich study). Circulation 1996;93:74–79.
Cornwall JV, Doré CJ, Lewis JD. Leg ulcers: epidemiology and aetiology. Br J Surg 1986;73:693–696.
Baker SR, Stacey MC, Singh G, Hoskin SE, Thompson PJ. Aetiology of chronic leg ulcers. Eur J Vasc Surg 1992;6:245–251.
Fowkes FGR, Callam MJ. Is arterial disease a risk factor for chronic leg ulceration? Phlebology 1994;9:87–90.
Nicolaides AN, Zukowski A, Lewis R, Kyprianou P, Malouf GM. Venous pressure measurements in venous problems. In: Bergan JJ, Yao JST, editors. Surgery of the veins. Orlando: Grune and Stratton, 1985:111–118.
Dodd H, Cockett FB. The pathology and surgery of the veins of the lower limb. Edinburgh: Churchill Livingstone, 1976.
Hoare MC, Nicolaides AN, Miles CR, Shull K, Jury RP, Needham T, Dudley HAF. The role of primary varicose veins in venous ulceration. Surgery 1982;92:450–453.
Kistner RL. Primary venous valve incompetence of the leg. Am J Surg 1980;140:218–224.
Pollack AA, Taylor BE, Myers TT, Wood EH. The effect of exercise and body position on the venous pressure at the ankle in patients having venous valvular defects. J Clin Invest 1949;28:559–563.
Nicolaides AN, Hussein MK, Szendro G, Christopoulos D, et al. The relation of venous ulceration with ambulatory venous pressure measurement. J Vasc Surg 1993;17:414–419.
Homans J. The aetiology and treatment of varicose ulcers of the leg. Surg Gynaecol Obstet 1917;24:300–311.
Fontaine R. Remarks concerning venous thrombosis and sequelae. Surgery 1957;41:6–24.
Blumhoff RL, Johnson G. Saphenous vein PpO2 in patients with varicose veins. J Surg Res 1977;23:35–36.
Scott HJ, Cheatle TR, McMullin GM, Coleridge Smith PD, Scurr JH. A reappraisal of the oxygenation of the venous blood of varicose veins. Br J Surg 1990;77:934–936.
Pratt GH. Arterial varices: a syndrome. Am J Surg 1949;77:456–460.
Brewer AC. Arteriovenous shunts. BMJ 1950;ii:270.
Lindmayr W, Lofferer O, Mostbeck A, Partsch H. Arteriovenous shunts in primary varicosis: a critical essay. Vasc Surg 1972;6:9–14.
Browse NL, Burnand KG. The cause of venous ulceration. Lancet 1982;ii:243–245.
Browse NL, Gray L, Jarrett PEM, Morland M. Blood and vein-wall fibrinolytic activity in health and vascular disease. BMJ 1977l;i:478–481.
Michel CC. Oxygen diffusion in oedematous tissue and through pericapillary cuffs. Phlebology 1990;5:223–230.
Stacey MC, Burnand KG, Layer GT, Pattison M. Transcutaneous oxygen tensions as a prognostic indicator and measure of treatment of recurrent ulceration. Br J Surg 1987;74:545.
Clyne CAC, Ramsden WH, Chant ADB, Wenster JHH. Oxygen tension in the skin of the gaiter area of limbs with venous ulceration. Br J Surg 1985;72:644–647.
Dodd HJ, Gaylarde PM, Sarkany I. Skin oxygen tension in venous insufficiency of the lower leg. J R Soc Med 1985;78:373–376.
Schmeller W, Roszinski S, Tronnier M, Gmelin E. Combined morphological and physiological examinations in lipodermatosclerosis. In: Raymond-Martimbeaux, Prescott R, Zummo M, editors. Phlebologie’ 92. Paris: John Libbey Eurotext, 1992:172–174.
Hopkins NFG, Spinks TJ, Rhodes CG, Ranicar ASOA, Jamieson CW. Positron emission tomography in venous ulceration and liposclerosis. BMJ 1982;286:333–336.
Sjerson P. Blood flow in cutaneous tissue in man studied by washout of radioactive xenon. Circ Res 1969;25:215–229.
Cheatle TR, McMullin GM, Farrah J, Coleridge Smith PD, Scurr JH. Three tests of microcirculatory function in the evaluation of treatment for chronic venous insufficiency. Phlebology 1990;5:165–172.
Stibe ECL, Cheatle TR, Coleridge Smith PD, Scurr JH. Liposclerotic skin: a diffusion block or a perfusion problem? Phlebology 1990;5:231–236.
Braide M, Amundson B, Chien S, Bagge U. Quantitative studies of leucocytes on the vascular resistance in a skeletal muscle preparation. Microvasc Res 1984;27:331–352.
Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid-Schoenbein GW. Accumulation of polymorphonuclear leucocytes during three hour myocardial ischemia. Am J Physiol 1986;251:H93–100.
Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016–1023.
Wilson JW. Leucocyte sequestration and morphologic augmentation in the pulmonary network following haemorrhagic shock and related forms of stress. Adv Microcirc 1972;??:197–232.
Linas SL, Shanley PF, Whittenburg D, Berger E, Repine JE. Neutrophils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol 1988;255:F728–F735.
Yamakawa T, Suguyama I, Niimi H. Behaviour of white blood cells in microcirculation of the cat brain cortex during hemorrhagic shock: intravital microscopic study. Int J Microcirc: Clin Exp 1984;3:554.
Braide M, Blixt A, Bagge U. Leukocyte effects on the vascular resistance and glomerular filtration of the isolated rat kidney at normal and low flow rates. Circ Shock 1986;20:71–80.
Weissman G, Smolen JE, Korchak HM. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 1980;303:27–34.
Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood 1984;64:959–966.
Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and the accumulation of white cells in the feet during venous stasis. Int J Microcirc: Clin Exp 1987;5:311–320.
Thomas PRS, Nash GB, Dormandy JA. White cell accumulation in the dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. BMJ 1988;296:1693–1695.
Scott HJ, McMullin GM, Coleridge Smith PD, Scurr JH. Venous ulceration and the role of the white blood cell. J Med Sci Tech 1990;14:184–187.
Bollinger A, Haselbach P, Schnewlin G, Junger M. Microangiopathy due to chronic venous incompetence evaluated by fluorescence videomicroscopy. In: Negus D, Jantet G, editors. Phlebology ‘85. London: John Libbey, 1986.
Franzeck UK, Speiser D, Haselbach P, Bollinger A. Morphologic and dynamic microvascular abnormalities in chronic venous incompetence (CVI). In: Davy A, Stemmer R, editors. Phlebologie ‘89. John Libbey Eurotext, 1989:104–107.
Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration: a new hypothesis. BMJ 1988;296:1726–1727.
Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. BMJ 1982;285:1071–1072.
Haselbach P, Vollenweider U, Moneta G, Bollinger A. Microangiopathy in severe chronic venous insufficiency evaluated by fluorescence video-microscopy. Phlebology 1986;1:159–169.
Wilkinson LS, Bunker C, Edwards JC, Scurr JH, Coleridge Smith PD. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 1993;17:669–675.
Veraart JC, Verhaegh ME, Neumann HA, Hulsmans RF, Arends JW. Adhesion molecule expression in venous leg ulcers. Vasa 1993;22:213–218.
Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MW. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 1992; 141:1085–1095.
Scott HJ, McMullin GM, Coleridge Smith PD, Scurr JH. A histological study into white blood cells and their association with lipodermatosclerosis and ulceration. Br J Surg 1990;78:210–211.
Falanga V, Kruskal J, Franks JJ. Fibrin-and fibrinogen-related antigens in patients with venous disease and venous ulceration. Arch Dermatol 1991;127:75–78.
Shields DA, Andaz S, Abeysinghe RD, Porter JB, Scurr JH, Coleridge Smith PD. Neutrophil activation in experimental ambulatory venous hypertension. Phlebology 1994;9:119–124.
Shields D, Andaz SK, Timothy-Antoine CA, Scurr JH, Porter JB. CD11b/CD18 as a marker of neutrophil adhesion in experimental ambulatory venous hypertension. In: Negus D, Jantet G, Coleridge Smith PD, editors. Phlebology’ 95. hlebology 1995;Suppl 1:108–109.
Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge-Smith PD. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 1997;26:265–23.
Shields DA, Andaz S, Abeysinghe RD, Porter JB, Scurr JH, Coleridge Smith PD. Plasma lactoferrin as a marker of white cell degranulation in venous disease. Phlebology 1994;9:55–58.
Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith PD. Plasma elastase in venous disease. Br J Surg 1994;81:1496–1499.
Shields D, Saharay M, Timothy-Antoine CA, Porter JB, Scurr JH. Neutrophil CD11b expression in patients with venous disease. In: Negus D, Jantet G, Coleridge Smith PD, editors. Phlebology ‘95. Phlebology ‘95. Phlebology 1995;Suppl 1:108–109.
Burnand KG, Whimster I, Clemenson G, Thomas ML, Browse NL. The relationship between the number of capillaries in the skin of the venous ulcer-bearing area of the lower leg and the fall in foot vein pressure during exercise. Br J Surg 1981;68:297–300.
Pardoe HD. The expression of angiogenic growth factors in the skin of patients with chronic venous disease of the lower limb. MSc thesis, University College London, 1996:1–61.
Franzeck UK, Speiser D, Haselbach P, Bollinger A. Morphologic and dynamic microvascular abnormalities in chronic venous incompetence (CVI). In: Davy A, Stemmer R, editors. Phlebologie ‘89. Paris: John Libbey Eurotext, 1989:104–107.
Chittenden SJ, Shami SK, Scurr JH, Coleridge Smith PD. Vasomotion in the leg skin of patients with chronic venous insufficiency. VASA 1992; in press.
Bollinger A, Isenring G, Franzeck UK. Lymphatic microangiopathy: a complication of severe chronic venous incompetence. Lymphology 1982;15:60–65.
Falanga V, Eaglstein WH. The “trap” hypothesis of venous ulceration. Lancet 1993;341:1006–1008.
Lagattolla NR, Stacey MC, Burnand KG, Gaffney PG. Growth factors, tissue and urokinase-type plasminogen activators in venous ulcers. Ann Cardiol Angeiol (Paris) 1995;44:299–303.
Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 1992;18:604–606.
Burgos H, Herd A, Bennett JP. Placental angiogenic and growth factors in the treatment of chronic varicose ulcers: preliminary communication. J R Soc Med 1989;82:598–599.
Bass A, Chayen D, Weinmann EE, Ziss M. Lateral venous ulcer and short saphenous vein insufficiency. J Vasc Surg 1997;25:654–657.
DePalma RG, Kowallek DL. Venous ulceration: a cross-over study from non-operative to operative treatment. J Vasc Surg 1996;24:788–792.
Layer GT, Stacey MC, Burnand KG. Stanozolol and the treatment of venous ulceration: an interim report. Phlebology 1986;1:197–203.
Sullivan GW, Carper HT, Novick WJ, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumour necrosis factor (alpha) on neutrophil function of pentoxifylline. Infect Immun 1988;56:1722–1729.
Colgan M-P, Dormandy JA, Jones PW, Schraibman IG, Shanik DG. Oxpentifylline treatment of venous ulcers of the leg. BMJ 1990;300:972–975.
Dale JJ, Ruckley CV, Harper DR, Gibson B, Nelson EA, Prescott RJ. A randomised double-blind placebo controlled trial of oxpentifylline in the treatment of venous leg ulcers. In Negus D, Jantet G, Coleridge Smith PD, editors. Phlebology ‘95. Phlebology 1995; Suppl 1:917–918.
Anon. Oxpentifylline for venous leg ulcers. Drug Ther Bull 1991;29:59–60.
Rudovsky G. Intravenous prostaglandin E1 in the treatment of venous ulcers: a double-blind, placebo-controlled trial. Vasa 1989; Suppl 28:39–43.
Wright DD, Franks PJ, Blair SD, Backhouse CM, Moffatt C, McCollum CN. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomised controlled trial. Br J Surg 1991;78:1269–1270.
Guilhou JJ, Dereure O, Marzin L, Ouvry P, Zuccarelli F, Debure C, et al. Efficacy of Dation 500 mg in venous leg ulcer healing: a double-blind, randomised, controlled versus placebo trial in 107 patients. Angiology 1997;48:77–85.
Rights and permissions
Copyright information
© 1999 Springer-Verlag London Limited
About this chapter
Cite this chapter
Coleridge-Smith, P.D. (1999). How Does a Leg Ulcerate?. In: Venous Disease. Springer, London. https://doi.org/10.1007/978-1-4471-0829-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0829-0_6
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1212-9
Online ISBN: 978-1-4471-0829-0
eBook Packages: Springer Book Archive